Found: 32
Select item for more details and to access through your institution.
Toward identification and intervention to address financial toxicity and unmet health‐related social needs among adolescents and emerging adults with cancer and their caregivers: A cross‐cultural perspective.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7197
- By:
- Publication type:
- Article
Incidence and prevalence of musculoskeletal health conditions in survivors of childhood and adolescent cancers: A report from the Swiss childhood cancer survivor study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7204
- By:
- Publication type:
- Article
Disparities in incidence and survival for patients with Ewing sarcoma in Florida.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7151
- By:
- Publication type:
- Article
An empirical analysis of overall survival in drug approvals by the US FDA (2006–2023).
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7190
- By:
- Publication type:
- Article
Off‐label prescribing of immune checkpoint inhibitor therapy at a single pediatric cancer center.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7154
- By:
- Publication type:
- Article
Review of patient‐reported outcomes (PROs) and non‐PROs in randomized controlled trials addressing head/neck cancers.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7036
- By:
- Publication type:
- Article
Identifying predictors of COVID‐related delays in cancer‐specific medical care.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7183
- By:
- Publication type:
- Article
The efficiency and safety of low‐dose apatinib combined with oral vinorelbine in pretreated HER2‐negative metastatic breast cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7181
- By:
- Publication type:
- Article
Long noncoding RNA small nucleolar RNA host genes as prognostic molecular biomarkers in hepatocellular carcinoma: A meta‐analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7200
- By:
- Publication type:
- Article
PD‐1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.6980
- By:
- Publication type:
- Article
Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7131
- By:
- Publication type:
- Article
Current treatment and novel insights regarding ROS1‐targeted therapy in malignant tumors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7201
- By:
- Publication type:
- Article
Prognostic implications of combining EGFR‐TKIs and radiotherapy in Stage IV lung adenocarcinoma with 19‐Del or 21‐L858R mutations: A real‐world study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7208
- By:
- Publication type:
- Article
Diagnostic performance of contrast‐enhanced mammography for suspicious findings in dense breasts: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7128
- By:
- Publication type:
- Article
Effects of resistance training on sleep quality and disorders among individuals diagnosed with cancer: A systematic review and meta‐analysis of randomized controlled trials.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7179
- By:
- Publication type:
- Article
Impact of immune‐related adverse events on survival outcomes in extensive‐stage small cell lung cancer patients treated with immune checkpoint inhibitors.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7188
- By:
- Publication type:
- Article
Adaptive radiotherapy for head and neck cancer: Pitfalls and possibilities from the radiation oncologist's point of view.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7192
- By:
- Publication type:
- Article
Flow cytometric minimal residual disease measurement accounting for cytogenetics in children with non‐high‐risk acute lymphoblastic leukemia treated according to the ALL‐MB 2008 protocol.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7172
- By:
- Publication type:
- Article
α‐Hederin induces paraptosis by targeting GPCRs to activate Ca<sup>2+</sup>/MAPK signaling pathway in colorectal cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7202
- By:
- Publication type:
- Article
Metabolite signature of human malignant thyroid tissue: A systematic review and meta‐analysis.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7184
- By:
- Publication type:
- Article
Could nutrition status predict fatigue one week before in patients with nasopharynx cancer undergoing radiotherapy?
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7191
- By:
- Publication type:
- Article
Association of leptin receptor polymorphisms with susceptibility of non‐small cell lung cancer: Evidence from 2249 subjects.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7178
- By:
- Publication type:
- Article
Survival trends for left and right sided colon cancer using population‐based SEER database: A forty‐five‐year analysis from 1975 to 2019.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7145
- By:
- Publication type:
- Article
Effectiveness and infectious complications of BCMA T‐cell engagers in treating multiple myeloma: Real‐world evidence from Sweden.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7048
- By:
- Publication type:
- Article
Understanding the financial cost of cancer clinical trial participation.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7185
- By:
- Publication type:
- Article
Survival and safety analysis of COVID‐19 vaccine in Chinese patients with non‐small cell lung cancer.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7032
- By:
- Publication type:
- Article
Six versus four or five cycles of first‐line etoposide and platinum‐based chemotherapy combined with thoracic radiotherapy in patients with limited‐stage small‐cell lung cancer: A propensity score‐matched analysis of a prospective randomized trial
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7215
- By:
- Publication type:
- Article
Trends in colorectal cancer screening compliance and incidence among 60‐ to 74‐year‐olds in China.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7133
- By:
- Publication type:
- Article
Outcomes of the transformation of follicular lymphoma to diffuse large B‐cell lymphoma in the rituximab era: A population‐based study.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.7120
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Cancer Medicine, 2024, v. 13, n. 8, p. 1, doi. 10.1002/cam4.6144
- Publication type:
- Article
Correction to "The adverse characteristics of hepatocellular carcinoma in the non‐cirrhotic liver disproportionately disadvantage black patients".
- Published in:
- 2024
- Publication type:
- Correction Notice
Correction to "Are embryonic stem cell markers and ALDH1A1 relevant in the context of breast cancer estrogen positivity".
- Published in:
- 2024
- Publication type:
- Correction Notice